Re: Infectious endophthalmitis after intravitreal injection of antiangiogenic agents

Retina. 2010 Nov-Dec;30(10):1752-4; author reply 1754. doi: 10.1097/IAE.0b013e3181fa4960.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiogenesis Inhibitors / adverse effects*
  • Anti-Bacterial Agents / therapeutic use
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal, Humanized
  • Aptamers, Nucleotide / adverse effects
  • Bevacizumab
  • Ceftazidime / therapeutic use
  • Drug Therapy, Combination
  • Endophthalmitis / drug therapy
  • Endophthalmitis / etiology*
  • Eye Infections / drug therapy
  • Eye Infections / etiology*
  • Humans
  • Intravitreal Injections / adverse effects*
  • Ranibizumab
  • Risk Factors
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / etiology*
  • Vancomycin / therapeutic use
  • Vitreous Body / microbiology

Substances

  • Angiogenesis Inhibitors
  • Anti-Bacterial Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Aptamers, Nucleotide
  • pegaptanib
  • Bevacizumab
  • Vancomycin
  • Ceftazidime
  • Ranibizumab